Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus

Journal of General Virology

Volumn 79, Issue 8, 1998, Pages 1895-1899

  Xie, Hong ^a   Ryman, Kate D ^a,b   Campbell, Gerald A ^a   Barrett, Alan D T ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS ATTENUATION; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION; VIRUS VIRULENCE; YELLOW FEVER FLAVIVIRUS;

ANIMALIA; FLAVIVIRUS; RNA VIRUSES; YELLOW FEVER VIRUS;

EID: 0031847633     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-8-1895     Document Type: Article

References (19)

1. Barrett, A. D. T. & Gould, E. A. (1986). Comparison of the neurovirulence of different strains of yellow fever virus in mice. Journal of General Virology 67, 631-637.
2. Barrett, A. D. T., Pryde, A., Medlen, A. R., Ledger, T. N., Whitby, J. E., Gibson, C. A., DeSilva, M., Groves, D. J., Langley, D. J. & Minor, P. D. (1989). Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies. Vaccine 7, 333-336.
3. Buckley, A. & Gould, E. A. (1985). Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. Journal of General Virology 66, 2523-2531.
4. Chambers, T. J., Hahn, C. S., Galler, R. & Rice, C. M. (1990). Flavivirus genome organization, expression and replication. Annual Reviews in Microbiology 44, 649-688.
5. Deubel, V., Crouset, J., Benichou, D., Digoutte, J. P., Bouloy, M. & Girard, M. (1983). Preliminary characterization of the ribonucleic acid of yellow fever virus. Annales de l'Institut Pasteur Virology 134E, 581-585.
6. Fitzgeorge, R. & Bradish, C. J. (1980). The in vivo differentiation of strains of yellow fever virus in mice. Journal of General Virology 46, 1-13.
7. Gould, E. A., Buckley, A., Barrett, A. D. T. & Cammack, N. (1986). Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67, 591-595.
8. Koonin, E. (1993). Computer-assisted identification of a putative methyltransferase domain in NS5 protein of flaviviruses and protein of reovirus. Journal of General Virology 74, 733-740.
9. Ledger, T. N., Sil, B. K., Wills, M. R., Lewis, G., Kinney, R., Jennings, A. D., Stephenson, J. R. & Barrett, A. D. T. (1992). Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies. Biologicals 20, 117-128.
10. Liprandi, F. (1981). Isolation of plaque variant differing in virulence from the 17D strain of yellow fever virus. Journal of General Virology 56, 363-370.
11. Liprandi, F. & Walder, R. (1983). Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophage-like cells (U937). Archive of Virology 76, 51-61.
12. Monath, T. P. (1995). Yellow fever and dengue. Seminars in Virology 5, 133-145.
13. Muylaert, I. R., Chambers, T. J., Galler, R. & Rice, C. M. (1996). Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on viral replication and mouse neurovirulence. Virology 222, 159-168.
14. Ni, H., Chang, G. J., Xie, H., Trent, D. W. & Barrett, A. D. T. (1995). Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. Journal of General Virology 76, 409-413.
15. Pletnev, A. G., Bray, M., Huggins, J. & Lai, C. J. (1992). Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proceedings of the National Academy of Sciences, USA 89, 10532-10536.
16. Rice, C. M., Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L. & Strauss, J. H. (1985). Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229, 726-733.
17. Tan, B. H., Fu, J., Sugrue, R. J., Yap, E. H., Chan, Y. C. & Tan, Y. H. (1996). Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology 216, 317-325.
18. Wang, E., Ryman, K. D., Jennings, A. D., Wood, D. J., Taffs, F., Minor, P. D., Sanders, P. G. & Barrett, A. D. T. (1995). Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. Journal of General Virology 76, 2744-2755.
19. Wang, E., Weaver, S. C., Shope, R. E., Tesh, R. B. & Watts, D. M. (1996). Genetic variation in yellow fever virus: duplication in the 3′ noncoding region of strains from Africa. Virology 225, 274-281.